Under construction – not a live service
Sign in
Taking peopleNo phase

Registry following people treated for brain blood vessel problems with Phenox devices

Follows people with brain aneurysms or vessel damage treated with Phenox devices.

Plain-language title generated from the registry record
Registry title: Targeting Real World Usage In Stroke Treatment

Key facts

Where
Basel and Sankt Gallen, SwitzerlandSee the 2 sites

Where in Switzerland

  • Universitätsspital BaselBasel, SwitzerlandNot yet recruiting
  • Kantonsspital St. GallenSankt Gallen, SwitzerlandNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Phenox GmbH
Trial code
NCT07474935
Record updated
16 March 2026
Original description
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.Read full original descriptionShow less

TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry

TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.

The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.

Inclusion: Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),; Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.

Exclusion: Participation in an interventional study modifying standard care management for all relevant indications,.

ClinicalTrials.gov NCT07474935